Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 3 Pancreatic Neoplasms 3 Cholangiocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Pharyngeal Neoplasms 1 Oropharyngeal Neoplasms 1 Oligometastatic Prostate Cancer 1 Mouth Neoplasms 1 Melanoma 1 Lung Diseases 1 Locally Advanced Pancreatic Cancer 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Liposarcoma 1 Laryngeal Neoplasms 1 Kidney Neoplasms 1 Hypopharyngeal Neoplasms 1

Interventions

Oxaliplatin 180 Capecitabine 174 Fluorouracil 154 Radiotherapy 107 Leucovorin 107 Irinotecan 93 Bevacizumab 69 Surgical Procedures, Operative 49 Cetuximab 39 Drug Therapy 38 Radiation 35 Neoadjuvant Therapy 33 Folfox protocol 29 Chemoradiotherapy 29 XELOX 22 Magnetic Resonance Spectroscopy 21 Chemotherapy, Adjuvant 21 Radiotherapy, Intensity-Modulated 19 Surveys and Questionnaires 17 Proctectomy 16 Biopsy 16 Early Intervention, Educational 14 trifluridine tipiracil drug combination 12 Panitumumab 12 Floxuridine 12 tislelizumab 11 regorafenib 11 Nivolumab 11 Laparoscopy 11 Celecoxib 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Rectal Neoplasms × zimberelimab × Clear all

NCT05024097 2025-08-27

PANTHER

Weill Medical College of Cornell University

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡